The Interactive Physical and Cognitive Exercise System

Summary

This study is intended to clarify the benefits to brain health and thinking processes that result from different forms of exercise. In particular, this study will investigate the possible benefits of physical exercise (such as pedaling an under-table stationary elliptical) or mental exercise (such as playing a videogame on a portable tablet), or combining these activities together (as in the iPACES™ exergame).

Conditions

• Alzheimer Disease, Early Onset
• MCI
• Aging
• Mild Cognitive Impairment
• Neurocognitive Disorder
• Cognitive Impairment
• Cognitive Change

Interventions

BEHAVIORAL

physical exercise alone (PES) first

following 2-week placebo for all participants, participants in this arm will then start their active intervention with a randomly assigned 2-week physical exercise-only intervention, then 2-week cognitive exercise-only intervention, then 2-week and 3 month intervals of iPACES™ (interactive physical and cognitive exercise)

DEVICE

cognitive exercise alone (iCE) first

following 2-week placebo for all participants, participants in this arm will then start their active intervention with a randomly assigned 2-week cognitive exercise-only intervention, then 2-week physical exercise-only intervention, then 2-week and 3 month intervals of iPACES™ (interactive physical and cognitive exercise)

DEVICE

interactive Physical and Cognitive Exercise (iPACES™)

following 2-week placebo for all participants, participants in this arm will then start their active intervention with a randomly assigned 2-week cognitive exercise-only intervention, then 2-week physical exercise-only intervention, then 2-week and 3 month intervals of iPACES™ (interactive physical and cognitive exercise)

Sponsors & Collaborators

• 1st Playable Productions

  collaborator OTHER

• Albany Medical College

  collaborator OTHER

• Skidmore College

  collaborator OTHER

• University of Illinois at Urbana-Champaign

  collaborator OTHER

• National Institute on Aging (NIA)

  collaborator NIH

• Union College, New York

  lead OTHER

Principal Investigators

• Cay Anderson-Hanley, PhD · Union College

Study Design

Allocation

NON_RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Model

CROSSOVER

Eligibility

Min Age

50 Years

Sex

ALL

Healthy Volunteers

Yes

Timeline & Regulatory

Start

2017-03-04

Primary Completion

2022-06-30

Completion

2022-06-30

FDA Device

Yes

Countries

• United States

Study Locations